Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Medical Genetics · Oculocutaneous Albinism

Why Is Genetic Testing Needed for Albinism?

At a Glance

Genetic testing for albinism is necessary because visual symptoms cannot distinguish standard oculocutaneous albinism from rare, life-threatening syndromic forms like Hermansky-Pudlak or Chediak-Higashi syndromes. Testing allows doctors to proactively manage severe bleeding or immune risks.

When your child is born with the unmistakable white or light hair, pale skin, and wandering eyes of albinism, a clinical diagnosis based on what you can see might feel like enough. It is entirely understandable to wonder why you would need expensive, time-consuming genetic testing to confirm something that seems visually obvious.

However, genetic testing is not just about confirming that your child has albinism—it is about finding out exactly which kind they have [1][2]. While non-syndromic forms like Oculocutaneous Albinism type 2 (OCA2) primarily affect pigmentation and vision, there are extremely rare but severe types of albinism that affect the internal organs. Genetic testing is the most reliable way to definitively rule out these dangerous “syndromic” forms of albinism, such as Hermansky-Pudlak Syndrome (HPS) and Chediak-Higashi Syndrome (CHS) [2][3][4]. It is important to know that these syndromes are very rare compared to standard albinism, but ruling them out is critical for your child’s safety.

Why Appearances Don’t Tell the Whole Story

A doctor’s physical exam and an eye exam alone are often not enough to distinguish between standard albinism and syndromic albinism [5][6]. This is especially true in babies and young children, because the dangerous internal symptoms of syndromic forms may not show up right away [7][8].

If a syndromic form of albinism is missed, the consequences can be life-threatening [2][9][10].

Hermansky-Pudlak Syndrome (HPS)

HPS is a rare condition that can look exactly like standard oculocutaneous albinism on the outside [11][2]. However, children with HPS have a defect in their blood platelets, leading to a severe bleeding tendency (known medically as a bleeding diathesis) [11][6].

  • Bleeding Risks: Because the blood doesn’t clot properly, even a minor surgery, a severe nosebleed, or a deep cut can become a medical emergency [12][13]. Knowing a child has HPS allows doctors to proactively manage this risk and arrange for necessary blood treatments before any surgical procedures [12][14].
  • Internal Organ Issues: HPS can also cause lung scarring (pulmonary fibrosis) and severe bowel inflammation that mimics Crohn’s disease [15][16]. Catching HPS early through genetics allows doctors to closely monitor lung and bowel function so treatments can begin as soon as problems arise [17][10].

Chediak-Higashi Syndrome (CHS)

CHS is another incredibly rare syndrome where albinism is accompanied by severe internal issues. Instead of a bleeding defect, CHS involves a profound defect in the immune system [18][19].

  • Severe Immune System Dysfunction: Children with CHS suffer from severe, recurring infections [20][21]. They are also at high risk for a life-threatening complication where the immune system attacks the body’s own organs [22][23].
  • Neurological Problems: CHS also causes progressive nerve damage and neurological decline [24][25]. The primary treatment to stop the immune failure in CHS is a bone marrow transplant, meaning early diagnosis through genetic testing is absolutely critical [20][26].

The Practicalities: Testing, Cost, and Results

Fortunately, the genetic test itself is minimally invasive for your baby, usually requiring just a simple blood draw or cheek swab.

While the upfront cost of genetic testing is a valid concern, many families find ways to navigate this barrier. A genetic counselor can often help you explore insurance coverage, financial assistance programs, or sponsored testing options available for patients with vision conditions.

Knowledge as Power

While it can be frightening to read about these severe syndromes, remember that genetic testing replaces “waiting and seeing” with hard data. If the test comes back as standard OCA2, you will gain immense peace of mind knowing you don’t need to worry about hidden organ damage or life-threatening bleeding disorders. If it comes back as HPS or CHS, your medical team can immediately implement a proactive screening and management plan [17][14][1].

It is also worth noting that genetic testing isn’t always perfectly conclusive. Sometimes, tests find “variants of uncertain significance,” meaning a genetic change is found but doctors aren’t sure yet what it means. A genetic counselor will be essential in helping you interpret these results and deciding on the best next steps for your child.

Common questions in this guide

Why can't a doctor diagnose my baby's type of albinism just by looking at them?
While the physical signs of standard albinism are obvious, rare forms of the condition involve hidden internal issues. A physical or eye exam alone cannot distinguish standard albinism from these severe, potentially life-threatening syndromes.
What are the dangerous forms of albinism?
Hermansky-Pudlak Syndrome (HPS) and Chediak-Higashi Syndrome (CHS) are two rare, dangerous forms of albinism. HPS causes severe bleeding risks and lung issues, while CHS causes profound immune system dysfunction.
How is the genetic test for albinism performed?
The genetic test is minimally invasive for infants and children. It typically requires only a simple blood draw or a quick, painless cheek swab to collect the necessary DNA.
What does a variant of uncertain significance mean on an albinism genetic test?
This result means a genetic change was found, but medical experts do not yet know if it causes health problems. A genetic counselor can help you interpret what this means for your child and advise you on the next steps for monitoring.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you refer us to a genetic counselor who can help us understand the testing process and navigate insurance or financial assistance options?
  2. 2.What type of sample (blood draw or cheek swab) does the genetic test require, and how long does it usually take to get the results?
  3. 3.If the genetic test results are inconclusive or show a variant of uncertain significance, what will our next steps be?
  4. 4.If we experience delays in getting the genetic testing done, what specific warning signs (like unusual bruising or severe infections) should we watch for in the meantime?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Children With Oculocutaneous Albinism Play Outside?Can People With Oculocutaneous Albinism (OCA) Drive?Does Oculocutaneous Albinism Type 2 Affect Intelligence?Does Skin & Hair Color Darken in OCA2? | Inciteful MedOCA2 Vision: Will My Child's Sight Improve Over Time?Do Oculocutaneous Albinism Type 2 Carriers Have Symptoms?How is Photophobia Managed in OCA2 Albinism?Is There Surgery for Nystagmus in Albinism (OCA2)?What Are the Chances of Passing on OCA2?What Does Melanoma Look Like in Albinism?What is Brown Albinism (BOCA) in OCA2?What is the Difference Between OCA1 and OCA2 Albinism?What is the Life Expectancy for Oculocutaneous Albinism 2?What School Accommodations Are Needed for OCA2 Albinism?Why Do Children With Albinism Tilt Their Heads?

References

References (26)
  1. 1

    Rapid Diagnosis and Subtyping of Hermansky-Pudlak Syndrome With Flow Cytometry Analysis.

    Zhang Y, Liu T, Yang Q, et al.

    Pigment cell & melanoma research 2025; (38(5)):e70048 doi:10.1111/pcmr.70048.

    PMID: 40913269
  2. 2

    Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising.

    Power B, Ferreira CR, Chen D, et al.

    Orphanet journal of rare diseases 2019; (14(1)):52 doi:10.1186/s13023-019-1023-7.

    PMID: 30791930
  3. 3

    Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.

    Yang Q, Yi S, Li M, et al.

    BMC medical genetics 2019; (20(1)):106 doi:10.1186/s12881-019-0842-7.

    PMID: 31196117
  4. 4

    A multilayered approach to the analysis of genetic data from individuals with suspected albinism.

    Sergouniotis PI, Michaud V, Lasseaux E, et al.

    Journal of medical genetics 2023; (60(12)):1245-1249 doi:10.1136/jmg-2022-109088.

    PMID: 37460203
  5. 5

    Clinical phenocopies of albinism.

    Dumitrescu AV, Pfeifer WL, Drack AV

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2021; (25(4)):220.e1-220.e8 doi:10.1016/j.jaapos.2021.03.015.

    PMID: 34280564
  6. 6

    Ocular findings and a comparative study of hair, skin and iris color in Chinese patients with albinism.

    Arcot Sadagopan K, Teng CH, Hui G, Lin DL

    Ophthalmic genetics 2023; (44(1)):54-69 doi:10.1080/13816810.2022.2135109.

    PMID: 36316991
  7. 7

    Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS.

    Michaud V, Lasseaux E, Plaisant C, et al.

    Pigment cell & melanoma research 2017; (30(6)):563-570 doi:10.1111/pcmr.12608.

    PMID: 28640947
  8. 8

    Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non-syndromic oculocutaneous albinism facilitates genetic diagnosis.

    Zhong Z, Gu L, Zheng X, et al.

    Pigment cell & melanoma research 2019; (32(5)):672-686 doi:10.1111/pcmr.12790.

    PMID: 31077556
  9. 9

    Novel genetic variant of HPS1 gene in Hermansky-Pudlak syndrome with fulminant progression of pulmonary fibrosis: a case report.

    Doubková M, Trizuljak J, Vrzalová Z, et al.

    BMC pulmonary medicine 2019; (19(1)):178 doi:10.1186/s12890-019-0941-4.

    PMID: 31619213
  10. 10

    Hermansky-Pudlak syndrome (HPS): a rare genetic interstitial lung disease.

    Ghosh S, Veluthat C, Venkatnarayan K, Ramachandran P

    BMJ case reports 2025; (18(4)) doi:10.1136/bcr-2025-265086.

    PMID: 40234069
  11. 11

    The presentation and outcomes of Hermansky-Pudlak syndrome in obstetrics and gynecological settings: A systematic review.

    Obeng-Tuudah D, Hussein BA, Hakim A, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2021; (154(3)):412-426 doi:10.1002/ijgo.13632.

    PMID: 33521972
  12. 12

    Genetic variants associated with Hermansky-Pudlak syndrome.

    Merideth MA, Introne WJ, Wang JA, et al.

    Platelets 2020; (31(4)):544-547 doi:10.1080/09537104.2019.1663810.

    PMID: 32436471
  13. 13

    Hermansky-Pudlak Syndrome: A Rare Cause of Post-polypectomy Bleeding.

    Baiomi A, Abbas H, Dev A

    Cureus 2021; (13(3)):e13781 doi:10.7759/cureus.13781.

    PMID: 33842157
  14. 14

    Novel variant in HPS3 gene in a patient with Hermansky Pudlak syndrome (HPS) type 3.

    Lecchi A, La Marca S, Femia EA, et al.

    Platelets 2020; (31(7)):960-963 doi:10.1080/09537104.2019.1704716.

    PMID: 31880485
  15. 15

    Hermansky-Pudlak Syndrome.

    Wang JY, Young LR

    Clinics in chest medicine 2025; (46(4)):701-710 doi:10.1016/j.ccm.2025.07.009.

    PMID: 41110930
  16. 16

    Infantile-onset inflammatory bowel disease in a patient with Hermansky-Pudlak syndrome: a case report.

    Ishihara J, Mizuochi T, Uchida T, et al.

    BMC gastroenterology 2019; (19(1)):9 doi:10.1186/s12876-019-0929-9.

    PMID: 30634918
  17. 17

    Novel mutation in two brothers with Hermansky Pudlak syndrome type 3.

    Sandrock-Lang K, Bartsch I, Buechele N, et al.

    Blood cells, molecules & diseases 2017; (67()):75-80 doi:10.1016/j.bcmd.2017.03.001.

    PMID: 28284561
  18. 18

    Detailed hair shaft analysis in a man with delayed-onset Chediak-Higashi syndrome.

    Veraitch O, Allison L, Vizcay-Barrena G, et al.

    The British journal of dermatology 2020; (182(1)):223-225 doi:10.1111/bjd.18341.

    PMID: 31301233
  19. 19

    Chediak-Higashi syndrome: a review of the past, present, and future.

    Sharma P, Nicoli ER, Serra-Vinardell J, et al.

    Drug discovery today. Disease models 2020; (31()):31-36 doi:10.1016/j.ddmod.2019.10.008.

    PMID: 33424983
  20. 20

    HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS - A PRESENTATION OF ACCELERATED PHASE OF CHEDIAK HIGASHI SYNDROME; CASE REPORT AND CLINICOPATHOLOGICAL REVIEW.

    Javed O, Kaleem B, Naveed S, et al.

    Journal of Ayub Medical College, Abbottabad : JAMC 2024; (36(2)):454-458 doi:10.555/JAMC-02-12731.

    PMID: 39610002
  21. 21

    Peripheral nervous system manifestations of Chediak-Higashi disease.

    Lehky TJ, Groden C, Lear B, et al.

    Muscle & nerve 2017; (55(3)):359-365 doi:10.1002/mus.25259.

    PMID: 27429304
  22. 22

    Chediak Higashi Syndrome with Hemophagocytic Lymphohistiocytosis.

    Safavi M, Parvaneh N

    Fetal and pediatric pathology 2023; (42(2)):259-262 doi:10.1080/15513815.2022.2077489.

    PMID: 35608383
  23. 23

    An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.

    Gil-Krzewska A, Saeed MB, Oszmiana A, et al.

    The Journal of allergy and clinical immunology 2018; (142(3)):914-927.e6 doi:10.1016/j.jaci.2017.10.040.

    PMID: 29241728
  24. 24

    Parkinsonism and Other Movement Disorders Associated with Chediak-Higashi Syndrome: Case Report and Systematic Literature Review.

    Balint B, Bhatia KP

    Movement disorders clinical practice 2015; (2(1)):93-98 doi:10.1002/mdc3.12111.

    PMID: 30363907
  25. 25

    Clinical Reasoning: A 50-Year-Old Man With Progressive Limb Weakness and Slurred Speech.

    Xie N, Yang G, Zhang W, et al.

    Neurology 2022; (98(14)):592-596 doi:10.1212/WNL.0000000000200008.

    PMID: 35145004
  26. 26

    [A novel mutation of the LYST gene in a Chinese family with Chediak-Higashi syndrome].

    Wang M, Qu LJ, Wang J, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2019; (57(12)):963-965 doi:10.3760/cma.j.issn.0578-1310.2019.12.015.

    PMID: 31795567

This page provides educational information about genetic testing for albinism. Always consult a genetic counselor or pediatric specialist to discuss appropriate testing options and care plans for your child.

Get notified when new evidence is published on Oculocutaneous albinism type 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.